Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

News on DePuy hip liability suits, U.S. v. Caronia and more.

You may also be interested in...



Reps. Fitzpatrick, Slaughter Introduce Device Defect Reform Bills

Reps. Mike Fitzpatrick, R-Pa., and cosponsor Louise Slaughter, D-N.Y., introduced medical device reform bills that would let courts consider product liability suits for PMA-approved devices and require physicians to report to FDA adverse events involving medtech products.

News Briefs: Device Tax Repeal Momentum; J&J Settles Hip Suit; Mobile Medical Apps Bill

Device tax repeal momentum. Johnson & Johnson/DePuy has settled a lawsuit from a California plaintiff related to injuries from the ASR hip implant. Rep. Marsha Blackburn is working on legislation to clarify FDA’s authority over mobile health apps. Zimmer will market Frontier’s Lateral Locking Cage. More news.

News In Brief

J&J scrutiny continues. New product launches. More news.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel